Patents by Inventor Sushant Malhotra

Sushant Malhotra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compounds for treating proliferative diseases
    Patent number: 7109229
    Abstract: The compounds disclosed herein are indolocarbazoles of Formula (I), which are potent CDK4 inhibitors, and are useful in the treatment of cell proliferative disorders, including cancer. Formula (I).
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: September 19, 2006
    Assignee: Eli Lilly and Company
    Inventors: Thomas Albert Engler, Kelly Wayne Furness, Sushant Malhotra, Stephen Lyle Briggs, Harold Burns Brooks, David K yes Clawson, Concepcion Sanchez-Martinez, Faming Zhang, Guoxin Zhu
  • Novel compounds as pharmaceutical agents
    Publication number: 20060058295
    Abstract: The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
    Type: Application
    Filed: November 24, 2003
    Publication date: March 16, 2006
    Applicant: Eli Lilly and Company
    Inventors: Douglas Beight, Timothy Burkholder, Todd Decollo, Alexander Godfrey, Charles Heap, Chi-Hsin King, Hong-Yu Li, William McMillen, Jason Sawyer, Yan Wang, Clive Diefenbacher, Thomas Engler, Sushant Malhotra, Sreenivasa Mundla
  • Kinase inhibitors
    Publication number: 20050288321
    Abstract: The present invention provides kinase inhibitors of Formula (I).
    Type: Application
    Filed: March 5, 2003
    Publication date: December 29, 2005
    Inventors: Pamela Albaugh, Jochen Ammenn, Timothy Burkholder, Joshu Clayton, Scott Conner, Brian Cunningham, Thomas Engler, Kelly Furness, James Henry, Sushant Malhotra, Mark Joseph Tebbe
  • Purine derivatives as kinase inhibitors
    Publication number: 20050090483
    Abstract: The present invention provides kinase inhibitors of Formula I.
    Type: Application
    Filed: March 4, 2003
    Publication date: April 28, 2005
    Inventors: Thomas Engler, Timothy Burkholder, Joshua Clayton, Clive Diefenbacher, Kelly Furness, James Henry, Yihong Li, Sushant Malhotra, Angela Marquart, Johnathan McLean, David Mendel, Jon Reel
  • Methods and compounds for treating proliferative diseases
    Publication number: 20040048915
    Abstract: The compounds disclosed herein are indolocarbazoles of Formula (I), which are potent CDK4 inhibitors, and are useful in the treatment of cell proliferative disorders, including cancer. Formula (I).
    Type: Application
    Filed: February 7, 2003
    Publication date: March 11, 2004
    Inventors: Thomas Albert Engler, Kelly Wayne Furness, Sushant Malhotra, Stephen Lyle Briggs, Harold Burns Brooks, David Keyes Clawson, Concepcion Sanchez-Martinez, Faming Zhang, Guoxin Zhu